Raleigh Capital Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-150
Closed -$3K 779
2022
Q3
$3K Sell
150
-29
-16% -$578 ﹤0.01% 573
2022
Q2
$4K Sell
179
-32
-15% -$646 ﹤0.01% 463
2022
Q1
$4K Sell
211
-129
-38% -$2.38K ﹤0.01% 478
2021
Q4
$4K Buy
+340
New +$5.77K ﹤0.01% 246

Other funds holding BTAL

Raleigh Capital Management's BTAL Position: Q4 2022 in Review

Raleigh Capital Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2022, closing a stake of 150 shares — an estimated $3K sold.

Raleigh Capital Management first reported a position in BTAL in Q4 2021 and held it in 4 quarters. The position peaked at $4K in Q2 2022. 80 funds tracked by Wall St. Rank hold BTAL as of Q4 2022.

  • Raleigh Capital Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2022 after selling out during the quarter.
  • Raleigh Capital Management sold 150 AGF US Market Neutral Anti-Beta Fund shares in Q4 2022, an estimated $3K.
  • Raleigh Capital Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2021 and held it in 4 quarters.
  • Raleigh Capital Management's AGF US Market Neutral Anti-Beta Fund position peaked at $4K in Q2 2022.
  • 80 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2022.

Based on Raleigh Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.